Landau Jeffrey B 4
4 · CytomX Therapeutics, Inc. · Filed Mar 21, 2024
Insider Transaction Report
Form 4
Landau Jeffrey B
Chief Business Officer
Transactions
- Sale
Common Stock
2024-03-19$2.09/sh−6,562$13,685→ 110,060 total
Holdings
- 4,500(indirect: By IRA)
Common Stock
- 3,180(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 64,802 restricted stock units.